These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28234656)

  • 1. Managing interactions between cognitive enhancers and other psychotropics.
    Tang SW; Tang WH; Leonard BE
    Int Clin Psychopharmacol; 2017 Jul; 32(4):175-183. PubMed ID: 28234656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A framework to avoid irrational polypharmacy in psychiatry.
    Zigman D; Blier P
    J Psychopharmacol; 2012 Dec; 26(12):1507-11. PubMed ID: 22767374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polypharmacy and geriatric psychiatry].
    Hamzaoui A; Joulié A; El Dachri Y
    Soins Gerontol; 2017; 22(127):17-21. PubMed ID: 28917331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy in psychiatric practice in the Canary Islands.
    De las Cuevas C; Sanz EJ
    BMC Psychiatry; 2004 Jul; 4():18. PubMed ID: 15236661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically relevant drug interactions between anticancer drugs and psychotropic agents.
    Yap KY; Tay WL; Chui WK; Chan A
    Eur J Cancer Care (Engl); 2011 Jan; 20(1):6-32. PubMed ID: 20030690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacy: when is it rational?
    Preskorn SH; Lacey RL
    J Psychiatr Pract; 2007 Mar; 13(2):97-105. PubMed ID: 17414685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in pharmacologic management of the hospitalized patient with psychiatric comorbidity.
    Ward M; Schwartz A
    J Hosp Med; 2013 Sep; 8(9):523-9. PubMed ID: 23913579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive, affective, and psychiatric features of Parkinson's disease.
    Barbas NR
    Clin Geriatr Med; 2006 Nov; 22(4):773-96, v-vi. PubMed ID: 17000335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of pharmacogenetics in psychiatry].
    Skrętkowicz J; Barańska M; Rychlik-Sych M
    Wiad Lek; 2013; 66(2 Pt 2):185-91. PubMed ID: 25775815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs are an acquired source of biological variance among patients.
    Preskorn SH
    J Psychiatr Pract; 2006 Nov; 12(6):391-6. PubMed ID: 17122699
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs.
    Kanner AM; Gidal BE
    Int Rev Neurobiol; 2008; 83():397-416. PubMed ID: 18929094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polypharmacy in psychiatric patients as an alternative to limited mental health resources].
    de las Cuevas C; Sanz EJ; de la Fuente JA; Cueto M
    Actas Esp Psiquiatr; 2005; 33(2):81-6. PubMed ID: 15768314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why drugs and hormones may interact in psychiatric disorders.
    Stahl SM
    J Clin Psychiatry; 2001 Apr; 62(4):225-6. PubMed ID: 11379834
    [No Abstract]   [Full Text] [Related]  

  • 15. Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics.
    Rittmannsberger H; Meise U; Schauflinger K; Horvath E; Donat H; Hinterhuber H
    Eur Psychiatry; 1999 Mar; 14(1):33-40. PubMed ID: 10572323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychotropic drugs].
    Müller-Spahn F
    Ther Umsch; 1999 Dec; 56(12):719-25. PubMed ID: 10638279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine.
    Crettol S; de Leon J; Hiemke C; Eap CB
    Clin Pharmacol Ther; 2014 Mar; 95(3):254-7. PubMed ID: 24196844
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of drug monotherapy in psychiatric inpatient treatment.
    Rittmannsberger H
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):547-51. PubMed ID: 11999906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avoiding psychotropic drug interactions in the cardiovascular patient.
    DeVane CL; Markowitz JS
    Bull Menninger Clin; 2000; 64(1):49-59. PubMed ID: 10695159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences and psychotropic polypharmacy in psychiatric patients in Brazil: a cross-sectional analysis of the PESSOAS Project.
    Costa JO; Ceccato MDGB; Melo APS; Acurcio FA; Guimarães MDC
    Cad Saude Publica; 2017 May; 33(4):e00168915. PubMed ID: 28538794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.